Cargando…
Replacement of hematopoietic system by allogeneic stem cell transplantation in myelofibrosis patients induces rapid regression of bone marrow fibrosis
Bone marrow fibrosis is a hallmark of primary and post ET/PV myelofibrosis. To investigated the impact of replacement of the hematopoietic system in myelofibrosis patients by allogeneic stem cell transplantation on bone marrow fibrosis, we studied bone marrow fibrosis on bone marrow samples from 24...
Autores principales: | Kröger, Nicolaus, Kvasnicka, Michael, Thiele, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368753/ https://www.ncbi.nlm.nih.gov/pubmed/23259545 http://dx.doi.org/10.1186/1755-1536-5-S1-S25 |
Ejemplares similares
-
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019) -
Allogeneic hematopoietic stem-cell transplantation for
myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020) -
Stem cell transplantation in myelofibrosis
por: Kröger, Nicolaus
Publicado: (2018) -
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis
por: Kvasnicka, Hans Michael, et al.
Publicado: (2018) -
State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019
por: McLornan, Donal P., et al.
Publicado: (2019)